Decitabine disrupts EBV genomic epiallele DNA methylation patterns around CTCF binding sites to increase chromatin accessibility and lytic transcription in gastric cancer [ChIP-seq]
To investigate the EBV genome after Decitabine treatment by CTCF ChIP-seq Overall design: Two EBV positive gastric cancer cell lines were treated with decitabine for 3days